Yaron Friedman, MD, Inc.
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rosen, Mark
NCT01562223: Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer

Active, not recruiting
N/A
30
US
motexafin gadolinium, Gadolinium
American College of Radiology Imaging Network, National Cancer Institute (NCI)
Prostate Cancer
12/22
12/22
NCT04876846: Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Recruiting
N/A
10
US
GEN 3 Monitoring of Fetus
Raydiant Oximetry, Inc.
Fetal Hypoxia
04/25
04/25
Pasqualy, Julie
NCT04876846: Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Recruiting
N/A
10
US
GEN 3 Monitoring of Fetus
Raydiant Oximetry, Inc.
Fetal Hypoxia
04/25
04/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rosen, Mark
NCT01562223: Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer

Active, not recruiting
N/A
30
US
motexafin gadolinium, Gadolinium
American College of Radiology Imaging Network, National Cancer Institute (NCI)
Prostate Cancer
12/22
12/22
NCT04876846: Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Recruiting
N/A
10
US
GEN 3 Monitoring of Fetus
Raydiant Oximetry, Inc.
Fetal Hypoxia
04/25
04/25
Pasqualy, Julie
NCT04876846: Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity

Recruiting
N/A
10
US
GEN 3 Monitoring of Fetus
Raydiant Oximetry, Inc.
Fetal Hypoxia
04/25
04/25

Download Options